Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials

A Pandit, MR Aryal, AA Pandit, L Jalota… - Heart, Lung and …, 2014 - Elsevier
Objective To review efficacy of percutaneous closure of patent foramen ovale compared with
medical therapy in prevention of recurrent strokes in patients with cryptogenic stroke …

Percutaneous PFO closure with Amplatzer PFO occluder: Predictors of residual shunts at 6 months follow‐up

M Greutmann, M Greutmann‐Yantiri… - Congenital heart …, 2009 - Wiley Online Library
Objective. The objective of this study was to assess predictors of residual shunts after
percutaneous patent foramen ovale (PFO) closure with Amplatzer PFO occluder (AGA …

Embolization and transcatheter retrieval of coils and devices

CA Tan, DS Levi, JW Moore - Pediatric cardiology, 2005 - Springer
Embolizations of coils and devices are well-known complications of transcatheter
procedures performed in order to occlude extracardiac or intracardiac shunts. A review of …

Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials

X Niu, G Ou-Yang, P Yan, S Huang, Z Zhang… - Journal of Neurology, 2018 - Springer
Objective This systematic review and meta-analysis was performed to investigate the
efficacy and safety of transcatheter device closure (TDC) plus anti-thrombotic drugs over …

Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism

C Spies, A Khandelwal, I Timmemanns… - Catheterization and …, 2008 - Wiley Online Library
Objectives: The aim of this article is to summarize our experience of patent foramen ovale
(PFO) closure in patients above the age of 55 years. Background: PFO is associated with …

[PDF][PDF] Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale

X Freixa, R Ibrahim, J Chan, P Garceau, A Dore… - …, 2013 - academia.edu
Aims: To describe the initial experience with the GORE® septal occluder (GSO), a new
septal occluder for the treatment of atrial septal defects (ASD) and patent foramen ovale …

Patent foramen ovale and cryptogenic stroke. A critical review

L Ballerini, A Cifarelli, A Ammirati… - Journal of …, 2007 - journals.lww.com
The underlying causes of ischemic stroke in young patients are often difficult to find, despite
systematic investigations concerning heart, coagulation system or any other type of vascular …

Transcatheter closure of atrial septal defects in children with a hypoplastic right ventricle

M Atiq, L Lai, KJ Lee, LN Benson - Catheterization and …, 2005 - Wiley Online Library
The efficacy and safety of device closure of atrial defects in children with complex congenital
heart disease and a hypoplastic right ventricle have not been detailed. The objective of this …

Impact of Interatrial Septum Anatomic Features on Short‐and Long‐T erm Outcomes After Transcatheter Closure of Patent Foramen Ovale: Single Device Type Versus …

G Rigatelli, F Dell'Avvocata… - Journal of …, 2013 - Wiley Online Library
Backgrounds We reported the short‐and long‐term results of our institutional single center
registry Interatrial Septum Interventions Study (ISIS) about the impact of different anatomic …

Follow‐up of residual shunt after patent foramen ovale closure

F Orzan, W Liboni, A Bonzano… - Acta neurologica …, 2010 - Wiley Online Library
Orzan F, Liboni W, Bonzano A, Molinari F, Ribezzo M, Rebaudengo N, Grippi G, Negri E.
Follow‐up of residual shunt after patent foramen ovale closure. Acta Neurol Scand: 2010 …